Anti-malignin antibody: Difference between revisions
CSV import Tags: mobile edit mobile web edit |
CSV import |
||
| Line 31: | Line 31: | ||
{{stub}} | {{stub}} | ||
{{No image}} | |||
Revision as of 06:36, 10 February 2025
Anti-malignin antibody (AMA) is a type of antibody that is found in the blood of some people who have cancer. It is used as a biomarker to detect the presence of cancer in the body. The presence of AMA in the blood can be detected through a blood test.
Overview
Anti-malignin antibody is a protein that the body's immune system produces in response to the presence of malignant cells. It is one of many types of antibodies that the immune system produces to fight off foreign substances in the body.
Detection
The presence of AMA in the blood can be detected through a blood test. This test is often used in conjunction with other tests to diagnose cancer. However, the presence of AMA in the blood does not necessarily mean that a person has cancer. Other conditions can also cause the immune system to produce AMA.
Use in Cancer Diagnosis
While the presence of AMA in the blood can be an indication of cancer, it is not a definitive diagnostic tool. Other tests, such as biopsy, imaging tests, and laboratory tests, are also necessary to confirm a diagnosis of cancer.
Limitations
The use of AMA as a biomarker for cancer has its limitations. Not all types of cancer cause the immune system to produce AMA. Furthermore, the presence of AMA in the blood can also be caused by other conditions, such as inflammation or infection. Therefore, a positive AMA test does not necessarily mean that a person has cancer.


